Oncology

High-risk lung cancer screening programs may be inefficient, lead to delays

Adherence to follow-up recommendations after a positive low-dose computed tomography (LDCT) lung cancer screening (LCS) are inconsistent, even in established programs, according to a study. “To achieve the LCS mortality benefit in clinical trials, timely, real-world follow-up of abnormal test results is necessary. Presently, annual LCS rates are lower than...